-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Advances in TCR Based Therapeutics for Hematologic Malignancies.

Program: Scientific Symposia
Session: Alternative Immune Effector Cells
Saturday, December 9, 2023, 2:00 PM-3:15 PM

Marie Bleakley, PhD, MBBS, MMSc

Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital and University of Washington, Seattle, WA; Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA

Disclosures: Bleakley: Miltenyi Biotec: Other: scientific advisory board meeting, Research Funding; Orca Bio: Consultancy; High Pass Bio/ Elevate Bio: Consultancy, Current equity holder in private company, Patents & Royalties, Research Funding; Promicell Therapeutics Inc: Patents & Royalties, Research Funding.